Concepedia

Emily Daze

ED

Statistics

Publications

5

Citations

202

H-Index

5

Active since

2019

Affiliations

Resverlogix (Canada)(Current)

Emily Daze is an author at Resverlogix (Canada) specializing in pharmacology, inflammation, and inflammation-related gene expression.

Publications per year

2019–2022

5

Publications

5

Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanism

Laura Tsujikawa, Li Fu, Shovon Das et al. · Clinical Epigenetics · 2019 · 126 citations · Full text

, , +17

The unrecognized importance of carbon stocks and fluxes from swamps in Canada and the USA

Scott J. Davidson, Emily Daze, Eunji Byun et al. · Environmental Research Letters · 2022 · 27 citations · Full text

, , +17

Epigenetic BET reader inhibitor apabetalone (RVX-208) counters proinflammatory aortic gene expression in a diet induced obesity mouse model and in human endothelial cells

Sylwia Wasiak, Laura Tsujikawa, Emily Daze et al. · Atherosclerosis · 2022 · 18 citations

, , +10

Prolactin-inducible EDD E3 ubiquitin ligase promotes TORC1 signalling, anti-apoptotic protein expression, and drug resistance in breast cancer cells.

Tyler MacDonald, Lynn N. Thomas, Emily Daze et al. · PubMed · 2019 · 17 citations · Full text

, , +17

Epigenetic Modulation by Apabetalone Counters Cytokine-Driven Acute Phase Response <i>In Vitro</i>, in Mice and in Patients with Cardiovascular Disease

Sylwia Wasiak, Dean Gilham, Emily Daze et al. · Cardiovascular Therapeutics · 2020 · 14 citations · Full text

, , +16

1–5 of 5